Jove
Visualize
お問い合わせ

関連する概念動画

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

106
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
106
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

1.2K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

160
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
160
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  2. アピカル・ハイパートロフィック・カルディオミオパシーにおける悪性不律の管理:症例報告
  1. ホーム
  2. アピカル・ハイパートロフィック・カルディオミオパシーにおける悪性不律の管理:症例報告

関連する実験動画

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

903

アピカル・ハイパートロフィック・カルディオミオパシーにおける悪性不律の管理:症例報告

Ramesh Acharya1, Gerardo Gutierrez-Sierra1, Vishakh Prakash1

  • 1Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, Paul L. Foster School of Medicine, The Hospitals of Providence-Transmountain, El Paso, TX, USA.

The American journal of case reports
|August 28, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

Apical hypertrophic cardiomyopathy (ApHCM) は,診断とリスクの階層化においてユニークな課題を提示しています. このケースは重度の心房不律症と パーソナライズされた治療の必要性を強調しています 特に併発性薬物使用障害の場合です

さらに関連する動画

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

14.9K

関連する実験動画

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

903
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

14.9K

科学分野:

  • 心臓病科
  • 遺伝学

背景:

  • Apical hypertrophic cardiomyopathy (ApHCM) は,しばしば特定の診断基準とリスクの階層化ガイドラインが欠けている珍しい変種です.
  • 他の形態の多動性心筋病と比べると,サルコメア変異と関連する頻度は少ない.

研究 の 目的:

  • 複合性併発症によるApHCMの症例を紹介し,臨床的表象と管理に焦点を当てます.
  • ApHCMにおける心拍不全のリスクと耐性心房不律の管理における課題を強調する.

主な方法:

  • 1型糖尿病とアルコール使用障害の 41歳の男性による症例報告 ApHCMの症状を示唆する.
  • 診断の評価にはエコーカルディオグラフィー,電解質の不均衡の評価,心室不律のモニタリングが含まれていた.
  • 治療には集中治療,心肺蘇生 (CPR) とインプラント可能な心動除細動器 (ICD) の導入が含まれていました.

主要な成果:

  • 患者には,APHCMに一致する重度の上部縮,重大な電解質の不均衡,および持続しない心室低血圧症 (NSVT) が示されました.
  • 彼は心房多形性短心症を発症し,心房細動 (VF) に進行し,心肺蘇生と集中治療を必要とした.
  • 急性心臓死亡の二次予防のために,ICDを成功裏に埋め込んだ.

結論:

  • このケースは,耐火性心室動脈不全を含む,ApHCMに関連した重大な心律異常リスクを強調しています.
  • 調整された管理戦略は,特に標準療法が禁忌となる併発性薬物使用障害の患者において極めて重要です.
  • Apical myectomyのような外科的選択肢は,選択されたApHCM患者の機能能力を改善する可能性があります.